At a recent EMEA webinar, “Changing Consumer Behavior and Digital Distribution in the COVID-19 World,” Jonathan Hughes and Anthony Miller presented insights about how consumers’ behavior is evolving amid COVID-19 in the short and long term: What are their major conce...

Read More

Why do some COVID-19 patients experience critically low blood-oxygen readings? Why has mechanical ventilation been of varying benefit? RGA's Heather Lund explores these and other pertinent questions surrounding COVID-19-associated coagulation abnormalities. Insights sha... Read More

RGA's Dr. John Lefebre draws on the words of Sir Winston Churchill when contemplating the likelihood of a second wave of COVID-19: “This is not the end. It is not even the beginning of the end. But it is, perhaps the end of the beginning”. What should insurers know?&...

Read More

Digital health behavior change applications are abundant, but low engagement statistics suggest they often don’t meaningfully respond to consumers’ motivations. It's easy for designers to see users’ long-term health needs while staying blind to the short-term motivat...

Read More

No one has been untouched by COVID-19. Forced isolation and fear of infection can leave profound social — and psychological — scars. RGA's Dr. Newman Harris explores the social and emotional dislocations caused by the pandemic and offers practical considerations for cla... Read More

As broad-based community testing for COVID-19 grows, understanding and interpreting results will be essential, yet many still struggle to distinguish between test types. RGA offers a guide and has updated its 

Read More

Explore developments head and neck cancers, stem cell transplantation, candida auris and more.
Read More

History exposes how disingenuous marketing and fake research can mislead the public for decades. RGA's Imran Lorgat explores the history of tobacco marketing and offers lessons for life and health insurers.  

Read More

In January of 2020, new graduates could look forward to a thriving job market; Then came COVID-19. Today, the global economy and job market are hardly recognizable, yet the insurance industry still needs bright and energetic professionals, perhaps now more than ever. RG... Read More

In this recording of the International Insurance Society (IIS) webinar “

Read More

Insurers are striving to better understand COVID-19-related mortality experience across age, underlying chronic health conditions, and gender – and yet finding and analyzing credible data has proven to be a daunting task.  

In this recording of ...

Read More

Read More

As the COVID-19 pandemic began to sweep across the world, reports of "panic buying" life insurance appeared in the media. RGA's Matt Battersby reviews the available data in Insurance Thought Leadership to determine i...

Read More

Curious about RGA's research?   Contact us to learn more. 

This video was developed in conjunction with actuview, ...

Read More

The emerging data on COVID-19 is incomplete and often contradictory, yet a growing body of evidence suggests comorbidities have a strong influence on risk stratification, both from the perspective of disease development, as well as early perspectives of long-term compli... Read More

Three leaders from RGA share their views from different, yet integrated, perspectives to help insurers make sense of the evolving global pandemic. Read More

RGA's Alan Hobbs explores how COVID-19 has created “little cheating” opportunities in the insurance application process that can eventually lead to a large economic impact for insurers. 

Read More

Although childhood COVID-19 differs from adult COVID-19, the virus can indeed cause serious illness in children. RGA's Dr. Paul Davis identifies emerging research into links between the virus and pediatric inflammatory syndromes and discusses rare, life-threatening m...

Read More

While severe respiratory complications of COVID-19 have received much media attention, emerging data indicates that renal disease is a major complication and a significant risk factor in death from the disease. RGA’s Dr. Georgiana Willwerth-Pascutiu, a nephrologist by p... Read More

As countries race to develop a vaccine for COVID-19, there is avid interest and debate regarding the possible role of bacille Calmette-Guérin (BCG). Could this vaccine prevent or reduce the severity of COVID-19? RGA's Dr. Sheetal Salgaonkar summarizes the research an...

Read More